Lisaftoclax
CAS: 2180923-05-9
Ref. TM-T10483
1mg | 293.00 € | ||
5mg | 644.00 € | ||
10mg | 921.00 € | ||
25mg | 1,366.00 € | ||
50mg | 1,839.00 € | ||
100mg | 2,489.00 € | ||
1ml*10 (DMSO) | 917.00 € |
Product Information
- Bcl-2/Bcl-xl inhibitor 1, APG-2575
Lisaftoclax (Bcl-2/Bcl-xl inhibitor 1) is an oral dual inhibitor of Bcl-2 and Bcl-xl, with IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl, respectively. Lisaftoclax is used to treat chronic lymphocytic leukemia (CLL) by inhibiting the action of the BCL-2 protein, which promotes the death of leukemia cells.
Chemical properties
Technical inquiry about: TM-T10483 Lisaftoclax
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.